» Articles » PMID: 27942777

Comparison of Peripheral Quantitative Computed Tomography Forearm Bone Density Versus DXA in Rheumatoid Arthritis Patients and Controls

Overview
Journal Osteoporos Int
Date 2016 Dec 13
PMID 27942777
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: RA is associated with generalized and periarticular osteoporosis. In addition to DXA that determines areal bone mineral density (BMD), peripheral QCT also detects volumetric BMD. QCT differentiates between total, trabecular, and cortical BMD. Here, we compared DXA and QCT in RA patients and healthy controls.

Methods: BMD of 57 female RA patients and 32 age-matched healthy female controls were assessed by DXA. QCT of the forearm ultradistal region was also performed. Densitometry data were correlated with age, disease duration, disease activity, serum CRP, and anti-CCP levels.

Results: Total bone density (310.4 ± 79.7 versus 354.0 ± 54.1 mg/cm; p = 0.007) and attenuation (0.37 ± 0.05 versus 0.40 ± 0.03 1/cm; p = 0.001), trabecular density (157.6 ± 57.0 versus 193.8 ± 48.7 mg/cm; p = 0.005) and attenuation (0.28 ± 0.03 versus 0.32 ± 0.04 1/cm; p < 0.0001), and cortical density (434.3 ± 115.8 versus 492.5 ± 64.0 mg/cm; p = 0.006) and attenuation (0.44 ± 0.07 versus 0.47 ± 0.04 1/cm; p = 0.004) were significantly lower in RA. Both lumbar and femoral neck BMD, as well as T-scores, were significantly lower in RA versus controls (p < 0.001 in all cases). In RA, total and cortical QCT attenuation and density were associated with age, the presence of RA, and their combination. In contrast, trabecular density and attenuation were only affected by the presence of the disease but not by age. Also in RA, total trabecular and cortical density as determined by QCT significantly correlated with lumbar and/or femoral neck BMD as measured by DXA. Finally, anti-CCP seropositivity was associated with lower trabecular density and attenuation.

Conclusions: Both DXA and QCT may be suitable to study bone metabolism in RA. Areal BMD determined by DXA may correlate with volumetric bone density measured by QCT. Moreover, trabecular osteoporosis may be associated by the underlying autoimmune-inflammatory disease, while cortical osteoporosis may rather be age-related.

Citing Articles

Bones or Stones: How Can We Apply Geophysical Techniques in Bone Research?.

Szekanecz Z, Besnyi A, Konya P, Furi J, Kiraly E, Bertalan E Int J Mol Sci. 2024; 25(19).

PMID: 39409063 PMC: 11477212. DOI: 10.3390/ijms251910733.


Bub1 suppresses inflammatory arthritis-associated bone loss in mice through inhibition of TNFα-mediated osteoclastogenesis.

Yoshida S, Ikedo A, Yanagihara Y, Sakaue T, Saeki N, Imai Y J Bone Miner Res. 2024; 39(3):341-356.

PMID: 38477771 PMC: 11240161. DOI: 10.1093/jbmr/zjae015.


Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases.

Soos B, Szentpetery A, Raterman H, Lems W, Bhattoa H, Szekanecz Z Nat Rev Rheumatol. 2022; 18(5):249-257.

PMID: 35273387 DOI: 10.1038/s41584-022-00764-w.


Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status.

Hamar A, Hascsi Z, Pusztai A, Czokolyova M, Vegh E, Petho Z RMD Open. 2021; 7(3).

PMID: 34740980 PMC: 8573670. DOI: 10.1136/rmdopen-2021-001804.


Associations of vascular and bone status in arthritis patients.

Pusztai A, Hamar A, Czokolyova M, Gulyas K, Horvath A, Vegh E Sci Rep. 2021; 11(1):19504.

PMID: 34593938 PMC: 8484288. DOI: 10.1038/s41598-021-99071-9.


References
1.
Schett G, Zwerina J, David J . The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol. 2008; 4(9):473-80. DOI: 10.1038/ncprheum0881. View

2.
Saario R, Sonninen P, Mottonen T, Viikari J, Toivanen A . Bone mineral density of the lumbar spine in patients with advanced rheumatoid arthritis. Influence of functional capacity and corticosteroid use. Scand J Rheumatol. 2000; 28(6):363-7. DOI: 10.1080/03009749950155355. View

3.
Daoussis D, Andonopoulos A, Liossis S . Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. Semin Arthritis Rheum. 2008; 39(5):369-83. DOI: 10.1016/j.semarthrit.2008.10.008. View

4.
Goldring S . Bone and joint destruction in rheumatoid arthritis: what is really happening?. J Rheumatol Suppl. 2002; 65:44-8. View

5.
Takayanagi H . Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009; 5(12):667-76. DOI: 10.1038/nrrheum.2009.217. View